Zetasizer Advance Range
Choose Zetasizer Ultra for lentivirus particle size, viral titer and zeta potential
Lentiviral vectors are powerful tools used to deliver genetic material into dividing and non-dividing cells, making them invaluable in the generation of cell therapies. By delivering their payload into the target cell, they enable the integration and continuous expression of therapeutic genes, which is essential for treating chronic diseases and genetic disorders.
Ensuring the quality of lentivirus vectors is crucial for the safety of these therapies. Characterization of lentivirus vectors involves measuring key parameters such as: size, titer and purity. Accurate measurement of these parameters reports on the stability of the lentivirus and minimizes potential risks.
Malvern Panalytical’s advanced analytical instruments provide quick and effortless sample purity and stability assessment of lentivirus vectors, providing detailed insights into their physical properties.
Choose Zetasizer Ultra for lentivirus particle size, viral titer and zeta potential
The Zetasizer Advance Ultra employs dynamic light scattering (DLS) and multi-angle dynamic light scattering (MADLS) technologies. Its key features for lentivirus vector characterization are:
Providing detailed information on particle size and stability, the Zetasizer Advance Ultra helps optimize lentivirus vector formulations to ensure consistent performance and accurately predict formulation stability.
Accurate size and titration analysis with NanoSight Pro
NanoSight Pro utilizes Nanoparticle Tracking Analysis (NTA) technology, supported by advanced software, to characterize nanoparticles in liquid suspension. Its key features in lentiviral vector characterization include:
Offering real-time visualization and high resolution analysis, NanoSight Pro enables researchers to gain a comprehensive understanding of their lentivirus vector samples.
Combining the capabilities of the NanoSight Pro and Zetasizer Advance Ultra can offer a more comprehensive approach to lentivirus vector characterization:
|
| |
Feature | NanoSight Pro | Zetasizer Advance Ultra |
---|---|---|
Measurement | Particle size, viral titer, and polydispersity | Particle size, viral titer, polydispersity and zeta potential |
Technology | Nanoparticle Tracking Analysis (NTA) | Dynamic Light Scattering (DLS) and Multi-Angle DLS (MADLS) |
Size range | 30-1000 nm | <1 nm to 10 μm |
Concentration Range | From 107 – 109 particles/mL | From 108 – 1013 particles/mL |
Size Measurement | Provides particle-by-particle size distribution with high-resolution | Rapid and precise hydrodynamic diameter measurement |
Polydispersity Handling | Excels with polydisperse samples and delivers immediate visual confirmation | Best suited for monodisperse or slightly polydisperse samples |
Zeta Potential | Not available | Measures zeta potential for surface charge and stability assessment |
Fluorescence Capability | Available for differentiating labeled particles with specific characteristics | Not available |
Visualization | Real-time visualization of particles and behaviors | Not available |
Data Output | Number-based size distributions | Intensity-weighted size distributions |
Sample Preparation | Minimal sample preparation, preserves integrity | Non-destructive, minimal sample preparation required |
Ideal Applications | Detailed analysis of polydisperse and dilute samples | Rapid characterization of small, monodisperse nanoparticles |
In some cases, the NanoSight Pro may be more suitable when detailed particle characterization is required, such as during the initial stages of lentivirus vector formulation development, when investigating aggregation issues or employing fluorescence to look at specific sample subpopulation. The Zetasizer Advance Ultra may be preferred for routine quality control, stability studies, and when zeta potential information is needed.
By leveraging the strengths of both instruments, researchers can achieve a more thorough understanding of lentivirus vectors, leading to improved efficacy and safety in gene therapy applications.